Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin and myoclonus

M H Van Woert, R Jutkowitz, D Rosenbaum

    Monographs in Neural Sciences
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Low brain serotonin may cause myoclonus. Supplementing with L-5-hydroxytryptophan (L-5-HTP) and carbidopa effectively reduced myoclonus symptoms, particularly in postanoxic cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial.

    Addiction science & clinical practice·2025
    Same author

    Where forest may not return in the western United States.

    Ecological indicators·2025
    Same author

    Evaluation of an online-based self-help intervention for patients with panic disorder - Study protocol for a randomized controlled trial.

    Internet interventions·2022
    Same author

    Multimodal Assessment of Smoking cue Reactivity During a Smoking Cue Exposure Task.

    Clinical EEG and neuroscience·2022
    Same author

    Psychedelics for psychological and existential distress in palliative and cancer care.

    Current oncology (Toronto, Ont.)·2019
    Same author

    Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
    Same journal

    Neurobiology of drug abuse.

    Monographs in neural sciences·1987
    Same journal

    Neurophysiological and neuropharmacological effects of opiates.

    Monographs in neural sciences·1987
    Same journal

    Neurobiology of phencyclidine.

    Monographs in neural sciences·1987
    Same journal

    Neuropharmacology of cocaine: role of monoaminergic systems.

    Monographs in neural sciences·1987
    Same journal

    Neurophysiological effects of opiates in the CNS.

    Monographs in neural sciences·1987
    Same journal

    Serotonergic mechanisms of hallucinogenic drug effects.

    Monographs in neural sciences·1987
    See all related articles

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Pharmacology

    Background:

    • Myoclonus is a neurological disorder characterized by involuntary muscle jerks.
    • Serotonin, a neurotransmitter, plays a crucial role in motor control.
    • Previous research suggests a link between serotonin metabolism and myoclonus.

    Purpose of the Study:

    • To investigate serotonin metabolism in patients with myoclonus.
    • To evaluate the therapeutic efficacy of L-5-hydroxytryptophan (L-5-HTP) combined with carbidopa for myoclonus treatment.

    Main Methods:

    • Biochemical analysis of serotonin metabolites in cerebrospinal fluid.
    • Clinical trial administering L-5-HTP and carbidopa to 19 myoclonus patients.
    • Assessment of myoclonus frequency and intensity before and after treatment.

    Related Experiment Videos

    Main Results:

    • Significantly decreased cerebrospinal fluid 5-hydroxyindoleacetic acid levels in patients with intention myoclonus.
    • Dramatic reduction in myoclonus frequency and intensity with L-5-HTP and carbidopa treatment.
    • Treatment was particularly effective in postanoxic intention myoclonus.

    Conclusions:

    • A deficiency in brain serotonin is implicated in the pathophysiology of myoclonus.
    • L-5-HTP plus carbidopa therapy shows promise for treating myoclonus by replenishing brain serotonin.
    • Potential side effects include anorexia, nausea, vomiting, diarrhea, and mental stimulation.